RCM
LUMO

RA Capital Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

RA Capital Management’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-55,556
Closed -$11M – 39
2013
Q4 		$11M Hold
55,556
– – 1.28% 19
2013
Q3 		$9.39M Buy
+55,556
New +$8.94M 0.98% 26

Other funds holding LUMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

RA Capital Management's LUMO Position: Q3 2015 in Review

RA Capital Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2015, closing a stake of 3,333 shares — an estimated $1.33M sold.

RA Capital Management first reported a position in LUMO in Q2 2013 and held it in 6 quarters. The position peaked at $36.3M in Q2 2013. 152 funds tracked by Wall St. Rank hold LUMO as of Q3 2015.

  • RA Capital Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • RA Capital Management sold 3,333 Lumos Pharma, Inc. Common Stock shares in Q3 2015, an estimated $1.33M.
  • RA Capital Management first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 6 quarters.
  • RA Capital Management's Lumos Pharma, Inc. Common Stock position peaked at $36.3M in Q2 2013.
  • 152 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2015.

Based on RA Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.